| Literature DB >> 28246599 |
Tao Jiang1, Jing Jiang2, Renping Wang3, Jianlin Lei4, Yang Zhou1.
Abstract
Purpose. To evaluate visual outcomes and identify prognostic factors after pars plana vitrectomy (PPV) surgery for traumatic endophthalmitis. Methods. Medical records of 121 consecutive patients (121 eyes) diagnosed with traumatic endophthalmitis that had undergone pars plana vitrectomy were retrospectively reviewed. Results. 121 patients, aged from 6 to 71 years, all underwent PPV surgery. 113 cases had improved best corrected visual acuity (BCVA) after surgery and 60% of them obtained BCVA better than fingers counting (FC). Good final visual prognosis was significantly associated with time between trauma and initial treatment less than 12 hrs (40% versus 98%; P < 0.001), time between trauma and PPV treatment less than 24 hrs (62% versus 98%; P < 0.001), laceration length less than 10 mm (63% versus 96%; P < 0.001), and presenting VA better than LP (42% versus 96%; P < 0.001), while gender, type of laceration, presence of IOFB or retinal detachment, and the use of silicone oil tamponade were not significant factors resulting in better BCVA. Bacteria were identified in 43.8% of specimens and most of the microorganisms were identified as nonvirulent ones. Conclusions. Pars plana vitrectomy surgery was preferred as a primary treatment option for traumatic endophthalmitis. A good final visual prognosis was significantly associated with timely treatment, prompt vitrectomy surgery, shorter length of laceration, and better presenting visual acuity.Entities:
Mesh:
Year: 2017 PMID: 28246599 PMCID: PMC5299176 DOI: 10.1155/2017/5851318
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
BCVA outcome pre/postoperatively.
| Visual acuity | Preoperatively (%) | Postoperatively (%) |
|---|---|---|
| NLP | 7 (5.79) | 5 (4.13) |
| LP | 35 (28.93) | 5 (4.13) |
| HM | 48 (39.67) | 16 (13.22) |
| FC | 27 (22.31) | 23 (19.01) |
| ⩽20/400 | 4 (3.31) | 31 (25.62) |
| 20/200~20/50 | 0 | 32 (26.45) |
| 20/50~20/40 | 0 | 6 (4.96) |
|
| 0 | 3 (2.48) |
NLP: no light perception; LP: light perception; HM: hand motion; FC: fingers counting.
Presentation features associated with better BCVA.
| Factor | Number | Improved BCVA (%) |
|
|---|---|---|---|
| Gender ( | |||
| Male | 103 | 98/103 (95.15) | 0.1781 |
| Female | 18 | 15/18 (83.3) | |
|
| |||
| Treatment period ( | |||
| <12 hrs | 111 | 109/111 (98.20) | 0.0000 |
| >12 hrs | 10 | 4/10 (40) | |
|
| |||
| PPV period ( | |||
| <24 hrs | 105 | 103/105 (98.10) | 0.0000 |
| >24 hrs | 16 | 10/16 (62.5) | |
|
| |||
| Laceration length ( | |||
| ⩽10 mm | 110 | 106/110 (96.36) | 0.0004 |
| >10 mm | 11 | 7/11 (63.63) | |
|
| |||
| Presenting VA ( | |||
|
| 114 | 110/114 (96.49) | 0.0000 |
| <LP | 7 | 3/7 (42.86) | |
|
| |||
| IOFB | |||
| Yes | 53 | 48/53 (90.57) | 0.4627 |
| No | 68 | 65/68 (95.59) | |
|
| |||
| Retinal detachment | |||
| Yes | 37 | 33/37 (89.19) | 0.4028 |
| No | 84 | 80/84 (95.24) | |
|
| |||
| Corneal perforation | |||
| Yes | 85 | 82/85 (96.47) | 0.0898 |
| No | 36 | 31/36 (86.11) | |
|
| |||
| Scleral perforation | |||
| Yes | 36 | 31/36 (86.11) | 0.0898 |
| No | 85 | 82/85 (96.47) | |
|
| |||
| SO use | |||
| Yes | 98 | 91/98 (92.86) | 0.9846 |
| No | 23 | 22/23 (95.65) | |
|
| |||
| Lensectomy | |||
| Yes | 116 | 109/116 (93.97) | 0.7555 |
| No | 5 | 4/5 (80) | |
PPV: pars plana vitrectomy; IOFB: intraocular foreign body; SO: silicone oil.
Summary of culture organisms.
| Culture-proven microorganisms | Eyes | Percentages (%) |
|---|---|---|
|
| 22 | 41.5 |
|
| 12 | 22.6 |
|
| 7 | 13.2 |
| Fungus | 4 | 7.5 |
| Other microorganisms | 8 | 15.1 |